Payal D Soni
Overview
Explore the profile of Payal D Soni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
630
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McLaughlin P, Cousins M, Tsodikov A, Soni P, Crook J
Sci Rep
. 2024 Mar;
14(1):5810.
PMID: 38461151
The extent to which PSA screening is related to prostate cancer mortality reduction in the United States (US) is controversial. US Surveillance, Epidemiology, and End Results Program (SEER) data from...
2.
Chao H, Soni P, Dahman B, Stilianoudakis S, Ford H, Singh R, et al.
Cancer Med
. 2022 Mar;
11(15):2886-2895.
PMID: 35289111
Background: The optimal upfront treatment modality for patients with nonmetastatic Gleason Score 9 and 10 prostate cancer (GS 9-10 PCa) is unknown. Methods: We conducted a retrospective cohort study of...
3.
Jackson W, Hartman H, Dess R, Birer S, Soni P, Hearn J, et al.
J Clin Oncol
. 2020 May;
38(26):3024-3031.
PMID: 32396488
Purpose: In men with localized prostate cancer, the addition of androgen-deprivation therapy (ADT) or a brachytherapy boost (BT) to external beam radiotherapy (EBRT) have been shown to improve various oncologic...
4.
Soni P, Spratt D
Semin Radiat Oncol
. 2019 Sep;
29(4):302-305.
PMID: 31472729
A principle goal of research in Oncology is to determine the optimal treatment for our patients. This often takes the form of comparing 2 existing therapies to one another to...
5.
Soni P, Hartman H, Schipper M, Spratt D
J Clin Oncol
. 2019 Aug;
37(29):2696-2697.
PMID: 31465259
No abstract available.
6.
Dess R, Hartman H, Mahal B, Soni P, Jackson W, Cooperberg M, et al.
JAMA Oncol
. 2019 May;
5(7):975-983.
PMID: 31120534
Importance: Black men are more likely to die of prostate cancer than white men. In men with similar stages of disease, the contribution of biological vs nonbiological differences to this...
7.
Jackson W, Suresh K, Tumati V, Dess R, Soni P, Zhao S, et al.
Eur Urol Oncol
. 2019 May;
1(4):276-282.
PMID: 31100248
Background: Disease progression following salvage radiotherapy (SRT) for prostate cancer (PC) is common, and the time to biochemical recurrence (BCR) is heterogeneous. Objective: To describe the temporal distribution and clinical...
8.
Dess R, Soni P, Jackson W, Berlin A, Cox B, Jolly S, et al.
Urol Oncol
. 2019 May;
37(9):599-610.
PMID: 31060795
Interstitial brachytherapy is one of several curative therapeutic options for the treatment of localized prostate cancer. In this review, we summarize all available randomized data to support the optimal use...
9.
Jackson W, Silva J, Hartman H, Dess R, Kishan A, Beeler W, et al.
Int J Radiat Oncol Biol Phys
. 2019 Apr;
104(4):778-789.
PMID: 30959121
Purpose: Utilization of stereotactic body radiation therapy (SBRT) for treatment of localized prostate cancer is increasing. Guidelines and payers variably support the use of prostate SBRT. We therefore sought to...
10.
Soni P
Int J Radiat Oncol Biol Phys
. 2019 Mar;
103(5):1058-1060.
PMID: 30900558
No abstract available.